Education
About Us
Working with TipRanks
Follow Us
Bal Pharma Limited (IN:BALPHARMA)
:BALPHARMA
Total Valuation
Bal Pharma Limited has a market cap or net worth of ₹1.58B. The enterprise value is ₹2.83B.
Market Cap₹1.58B
Enterprise Value₹2.83B
Share Statistics
Bal Pharma Limited has 15,920,872 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding15,920,872
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bal Pharma Limited’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 11.85%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)11.85%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.90
Inventory Turnover2.23
Valuation Ratios
The current PE Ratio of Bal Pharma Limited is 0.00. Bal Pharma Limited’s PEG ratio is 0.73.
PE Ratio0.00
PS Ratio0.00
PB Ratio1.51
Price to Fair Value0.00
Price to FCF-120.29
Price to Operating Cash Flow12.97
PEG Ratio0.73
Income Statement
In the last 12 months, Bal Pharma Limited had revenue of 3.03B and earned 72.15M in profits. Earnings per share was 4.56.
Revenue3.03B
Gross Profit730.18M
Operating Income197.89M
Pretax Income51.38M
Net Income72.15M
EBITDA317.63M
Earnings Per Share (EPS)4.56
Cash Flow
In the last 12 months, operating cash flow was 59.25M and capital expenditures 0.00, giving a free cash flow of 59.25M billion.
Operating Cash Flow59.25M
Free Cash Flow59.25M
Free Cash Flow per Share3.72
Dividends & Yields
Bal Pharma Limited pays an annual dividend of ₹1.2, resulting in a dividend yield of 1.21%
Dividend Per Share₹1.2
Dividend Yield1.21%
Payout Ratio26.55%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.66
52-Week Price Change-15.82%
50-Day Moving Average101.40
200-Day Moving Average112.58
Relative Strength Index (RSI)47.46
Average Volume (3m)2.97K
Important Dates
Bal Pharma Limited upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 29, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend DateSep 17, 2024
Financial Position
Bal Pharma Limited as a current ratio of 1.07, with Debt / Equity ratio of 185.32%
Current Ratio1.07
Quick Ratio0.60
Debt to Market Cap0.00
Net Debt to EBITDA4.48
Interest Coverage Ratio1.17
Taxes
In the past 12 months, Bal Pharma Limited has paid -20.99M in taxes.
Income Tax-20.99M
Effective Tax Rate-0.41
Enterprise Valuation
Bal Pharma Limited EV to EBITDA ratio is 4.48, with an EV/FCF ratio of -9.78.
EV to Sales0.47
EV to EBITDA4.48
EV to Free Cash Flow-9.78
EV to Operating Cash Flow33.64
Balance Sheet
Bal Pharma Limited has ₹261.56M in cash and marketable securities with ₹1.55B in debt, giving a net cash position of ₹1.29B billion.
Cash & Marketable Securities₹261.56M
Total Debt₹1.55B
Net Cash₹1.29B
Net Cash Per Share₹80.90
Tangible Book Value Per Share₹0.00
Margins
Gross margin is 46.53%, with operating margin of 6.53%, and net profit margin of 2.38%.
Gross Margin46.53%
Operating Margin6.53%
Pretax Margin1.70%
Net Profit Margin2.38%
EBITDA Margin10.48%
EBIT Margin7.26%
Analyst Forecast
The average price target for Bal Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―